BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 9663210)

  • 1. Complications of motility peg placement in hydroxyapatite implants.
    Jordan DR
    Ophthalmology; 1998 Jul; 105(7):1128-9. PubMed ID: 9663210
    [No Abstract]   [Full Text] [Related]  

  • 2. Complications of motility peg placement for the hydroxyapatite orbital implant.
    Edelstein C; Shields CL; De Potter P; Shields JA
    Ophthalmology; 1997 Oct; 104(10):1616-21. PubMed ID: 9331200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complications of hydroxyapatite orbital implants.
    Massry GG; Holds JB
    Ophthalmology; 1997 Sep; 104(9):1368-9. PubMed ID: 9307626
    [No Abstract]   [Full Text] [Related]  

  • 4. Difficulties with hydroxyapatite orbital implants in two patients with dysfunctional levator/superior rectus muscle complex.
    Wachler BS; Holds JB
    Ophthalmic Plast Reconstr Surg; 1997 Dec; 13(4):252-5. PubMed ID: 9430301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary placement of a hydroxyapatite-coated sleeve in bioceramic orbital implants.
    Liao SL; Shih MJ; Lin LL
    Am J Ophthalmol; 2005 Feb; 139(2):235-41. PubMed ID: 15733982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hydroxyapatite intraorbital implants].
    Fendri M; Beltaief O; Krichen S; Charfi O; Matri L; Triki MF
    Tunis Med; 1995; 73(6-7):241-5. PubMed ID: 9506172
    [No Abstract]   [Full Text] [Related]  

  • 7. Draining cutaneous fistula associated with infection of hydroxyapatite orbital implant.
    Glasgow BJ; Weinberg DA; Shorr N; Goldberg RA
    Ophthalmic Plast Reconstr Surg; 1996 Jun; 12(2):131-5. PubMed ID: 8727180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complications of hydroxyapatite orbital implants. A review of 100 consecutive cases and a comparison of Dexon mesh (polyglycolic acid) with scleral wrapping.
    Oestreicher JH; Liu E; Berkowitz M
    Ophthalmology; 1997 Feb; 104(2):324-9. PubMed ID: 9052640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repairing the hole in hydroxyapatite orbital implants following peg removal.
    Jordan DR
    Ophthalmic Surg Lasers; 2000; 31(5):438-40. PubMed ID: 11011717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of tissue breakdown and exposure associated with orbital hydroxyapatite implants.
    el-Shahed FS; Sherif MM; Ali AT
    Ophthalmic Plast Reconstr Surg; 1995 Jun; 11(2):91-4. PubMed ID: 7654623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of hydroxyapatite implants.
    Sloan BH; McNab AA
    Ophthalmology; 1997 Dec; 104(12):1982-3. PubMed ID: 9400753
    [No Abstract]   [Full Text] [Related]  

  • 12. Improved prosthetic motility with placement of a second coupling PEG.
    Gilliland GD; Trawnik R; Harrington JN
    Ophthalmic Plast Reconstr Surg; 2003 Mar; 19(2):123-7. PubMed ID: 12644758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Secondary reconstruction of anophthalmic orbits by intraorbital biomaterial implantation].
    Adenis JP; Bertin P; Robert PY
    J Fr Ophtalmol; 1999 Mar; 22(2):269-73. PubMed ID: 10327362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative motility of hydroxyapatite and alloplastic enucleation implants.
    Custer PL; Trinkaus KM; Fornoff J
    Ophthalmology; 1999 Mar; 106(3):513-6. PubMed ID: 10080207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late onset ureteric obstruction after endoscopic subureteric injection of calcium hydroxyapatite for primary vesicoureteric reflux.
    Zaccara A; Castagnetti M; Beniamin F; Rigamonti W
    Urology; 2007 Oct; 70(4):811.e1-3. PubMed ID: 17991568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complications of hydroxyapatite orbital implants in children: a series of 105 cases].
    Lumbroso L; Levy C; Plancher C; Validire P; Asselain B; Doz F; Schlienger P; Desjardins L
    J Fr Ophtalmol; 2000 Mar; 23(3):249-54. PubMed ID: 10740051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary placement of hydroxyapatite-coated sleeves in bioceramic orbital implants.
    Jordan DR
    Am J Ophthalmol; 2005 Feb; 139(2):333-4. PubMed ID: 15733997
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral Pathology Quiz #56. Case number 4. Implant material.
    J N J Dent Assoc; 2007; 78(3):23, 31. PubMed ID: 17974071
    [No Abstract]   [Full Text] [Related]  

  • 19. Porous orbital implants, wraps, and PEG placement in the pediatric population after enucleation.
    Wang JK; Liao SL; Lin LL; Kao SC; Tseng HS
    Am J Ophthalmol; 2007 Jul; 144(1):109-116. PubMed ID: 17499206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure rate of hydroxyapatite orbital implants a 15-year experience of 802 cases.
    Yoon JS; Lew H; Kim SJ; Lee SY
    Ophthalmology; 2008 Mar; 115(3):566-572.e2. PubMed ID: 17854900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.